BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

 
Clonorchis sinensis, an Oriental Liver Fluke, as a Human Biological Agent (Carcinogen) of Cholangiocarcinoma: A Brief Review
Tong-Soo Kim1, Jhang Ho Pak2, Jong-Bo Kim3, Young Yil Bahk3,*
1Department of Parasitology and Tropical Medicine, School of Medicine, Inha University, Incheon, 22212, Korea,
2Department of Convergence Medicine, College of Medicine, University of Ulsan, Asan Institute for Life Sciences, Asan Medical Center, Seoul, 05505, Korea,
3Department of Biotechnology, Konkuk University, Chungju, 27478, Korea
Abstract
Parasitic diseases remain an unarguable public health problem in the world. Liver fluke Clonorchis sinensis is a high risk pathogenic parasitic helminth endemic predominantly in Asian countries, including Korea, China, Taiwan, Vietnam, and the far eastern part of Russia, which still actively transmitted. According to the last 8th National Survey on the Prevalence of Intestinal Parasitic Infections in 2012, C. sinensis, whose prevalence was 1.86% in general population, revealed the highest prevalence parasite among all parasite species surveyed in Korea. This fluke is now classified in one of definite Group 1 human biological agents (carcinogens) by International Agency of Research on Cancer (IARC) together with two other parasites, Opisthorchis viverrini and Schistosoma haematobium. C. sinensis infestation is mainly linked to liver and biliary disorders, especially cholangiocarcinoma (CCA). For the purposes of this mini-review, we will only focus to C. sinensis and review pathogenesis and carcinogenesis of clonorchiasis, disease condition by C. sinensis infestation, and association between C. sinensis infestation and CCA. Here, we briefly consider the current scientific status for progression of CCA by heavy C. sinensis infestation from this food-borne trematode and development of CCA.
Abstract, Accepted Manuscript(in press) [Submitted on July 4, 2016, Accepted on July 4, 2016]
  © KSBMB. All rights reserved. / Powered by INFOrang Co., Ltd